Cosentyx, a medication used to treat various autoimmune diseases, including psoriatic arthritis, rheumatoid arthritis, and plaque psoriasis, remains available in the market, although its patent for use in some of these applications is set to expire [1]. There are no available reports or statements from the manufacturer, Novartis, indicating that Cosentyx has been discontinued.

On DrugPatentWatch.com, you can find information about the patent status of Cosentyx [2]. This website tracks the patent information of various medications, including when the patents are set to expire, enabling users to stay informed about potential generic versions becoming available.

As of my last knowledge update, Cosentyx is still being marketed and sold by Novartis. If you are concerned about the availability of Cosentyx or need more information, you should consult your healthcare provider or the manufacturer.

Sources:

[1] https://www.drugpatentwatch.com/drugs/Cosentyx

[2] https://www.drugpatentwatch.com/